Current
41.4×
5-Year Average
51.7×
All-Time High
90.8×
All-Time Low
17.8×
P/E Ratio daily chart for IDEXX Laboratories (IDXX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for IDEXX Laboratories (IDXX) from 2001 to 2025
| 2025 | $54.19B | $1.06B | 51.1× | +13.0× | |
| 2024 | $33.84B | $887.87M | 38.1× | -16.5× | |
| 2023 | $46.12B | $845.04M | 54.6× | +4.8× | |
| 2022 | $33.83B | $679.09M | 49.8× | -25.2× | |
| 2021 | $55.86B | $744.85M | 75.0× | +1.5× | |
| 2020 | $42.73B | $581.78M | 73.5× | +21.0× | |
| 2019 | $22.42B | $427.72M | 52.4× | +9.8× | |
| 2018 | $16.07B | $377.03M | 42.6× | -9.3× | |
| 2017 | $13.67B | $263.14M | 52.0× | +4.8× | |
| 2016 | $10.47B | $222.04M | 47.2× | +12.7× | |
| 2015 | $6.62B | $192.08M | 34.5× | -4.4× | |
| 2014 | $7.08B | $181.91M | 38.9× | +9.5× | |
| 2013 | $5.53B | $187.80M | 29.4× | +0.9× | |
| 2012 | $5.08B | $178.27M | 28.5× | +2.2× | |
| 2011 | $4.25B | $161.79M | 26.3× | -1.9× | |
| 2010 | $3.98B | $141.28M | 28.1× | +2.8× | |
| 2009 | $3.10B | $122.22M | 25.4× | +7.0× | |
| 2008 | $2.13B | $116.17M | 18.4× | -19.6× | |
| 2007 | $3.57B | $94.01M | 38.0× | +11.6× | |
| 2006 | $2.47B | $93.68M | 26.4× | -2.9× | |
| 2005 | $2.29B | $78.25M | 29.3× | +6.3× | |
| 2004 | $1.80B | $78.33M | 23.0× | -5.2× | |
| 2003 | $1.61B | $57.09M | 28.2× | +3.9× | |
| 2002 | $1.10B | $45.39M | 24.2× | -1.4× | |
| 2001 | $966.00M | $37.62M | 25.7× | — |
- 202551.1×
- 202438.1×
- 202354.6×
- 202249.8×
- 202175.0×
- 202073.5×
- 201952.4×
- 201842.6×
- 201752.0×
- 201647.2×
- 201534.5×
- 201438.9×
- 201329.4×
- 201228.5×
- 201126.3×
- 201028.1×
- 200925.4×
- 200818.4×
- 200738.0×
- 200626.4×
- 200529.3×
- 200423.0×
- 200328.2×
- 200224.2×
- 200125.7×
About P/E Ratio at IDEXX Laboratories (IDXX)
IDEXX Laboratories (IDXX) P/E ratio is 41.4× as of June 5, 2026. The 5-year average is 51.7×. The sector median currently stands at 25.0×. The current ratio is at the 10th percentile of its own 10-year history.
IDEXX Laboratories (IDXX) historical P/E ratio has ranged from a low of 17.8× (2009) to a high of 90.8× (2021) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
IDEXX Laboratories P/E Ratio by Year
IDEXX Laboratories P/E Ratio 2025: 51.1×
IDEXX Laboratories (IDXX) P/E ratio in 2025 was 51.1×, expanded from 38.1× the prior year.
IDEXX Laboratories P/E Ratio 2024: 38.1×
IDEXX Laboratories (IDXX) P/E ratio in 2024 was 38.1×, contracted from 54.6× the prior year.
IDEXX Laboratories P/E Ratio 2023: 54.6×
IDEXX Laboratories (IDXX) P/E ratio in 2023 was 54.6×, expanded from 49.8× the prior year.
IDEXX Laboratories P/E Ratio 2022: 49.8×
IDEXX Laboratories (IDXX) P/E ratio in 2022 was 49.8×, contracted from 75.0× the prior year.
IDEXX Laboratories P/E Ratio 2021: 75.0×
IDEXX Laboratories (IDXX) P/E ratio in 2021 was 75.0×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of IDEXX Laboratories (IDXX), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric